Leptin antagonism attenuates hypertension and renal injury in an experimental model of autoimmune disease.Published in:Clinical Science, 2023, v. 137, n. 23, p. 1771, doi. 10.1042/CS20230924By:Kalusche, William J.;Case, Clinton T.;Taylor, Erin B.Publication type:Article
Correction: The vascular Na,K-ATPase: clinical implications in stroke, migraine, and hypertension.Published in:Clinical Science, 2023, v. 137, n. 23, p. 1787, doi. 10.1042/CS-2022-0796C_CORPublication type:Article